In a mouse model of degenerative fibrosarcoma, cDC2s expressing IFN-stimulated genes can acquire and present intact tumor-derived peptide/MHC class I complexes that activate antitumor CD8+ T cell responses [147]. This evidence concerns the gene CD8A and neoplasm.